【24h】

Imaging Biomarker Discovery for Lung Cancer Survival Prediction

机译:成像生物标志物发现对肺癌存活率的预测

获取原文

摘要

Solid tumors are heterogeneous tissues composed of a mixture of cells and have special tissue architectures. However, cellular heterogeneity, the differences in cell types are generally not reflected in molecular profilers or in recent histopathological image-based analysis of lung cancer, rendering such information underused. This paper presents the development of a computational approach in H&E stained pathological images to quantitatively describe cellular heterogeneity from different types of cells. In our work, a deep learning approach was first used for cell subtype classification. Then we introduced a set of quantitative features to describe cellular information. Several feature selection methods were used to discover significant imaging biomarkers for survival prediction. These discovered imaging biomarkers are consistent with pathological and biological evidence. Experimental results on two lung cancer data sets demonstrated that survival models bsuilt from the clinical imaging biomarkers have better prediction power than state-of-the-art methods using molecular profiling data and traditional imaging biomarkers.
机译:实体瘤是由细胞混合物组成的异质组织,具有特殊的组织结构。但是,细胞异质性,细胞类型的差异通常未反映在分子谱仪中或近期基于肺癌的基于组织病理学图像的分析中,从而使此类信息的使用不足。本文介绍了H&E染色病理图像中计算方法的发展,以定量描述来自不同类型细胞的细胞异质性。在我们的工作中,首先将深度学习方法用于细胞亚型分类。然后,我们介绍了一组定量特征来描述细胞信息。几种特征选择方法被用来发现重要的成像生物标志物以进行生存预测。这些发现的成像生物标志物与病理和生物学证据一致。在两个肺癌数据集上的实验结果表明,与使用分子谱数据和传统成像生物标志物的最新技术相比,临床成像生物标志物建立的生存模型具有更好的预测能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号